Brief: Corvus Pharmaceuticals Announces Pricing Of Upsized Public Offering Of Common Stock
22/01/2026 03:54
Jan 21 (Reuters) - Corvus Pharmaceuticals Inc CRVS.O: CORVUS PHARMACEUTICALS ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK CORVUS PHARMACEUTICALS INC - PRICES UPSIZED PUBLIC OFFERING AT $22.15 PER SHARE Source text: ID:nGNXbDbPWb Further company coverage: CRVS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corvus Pharmaceuticals
See all newsBrief: Corvus Pharmaceuticals Announces Initiation Of Phase 1B Clinical Trial Of Soquelitinib For Patients With Hidradenitis Suppurativa
Corvus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental